Regulations.gov document
FDA Response re Certain Products Containing Bendamustine
Other · FDA-2018-N-3773 · posted Feb 20, 2019
Key facts
| Document ID | FDA-2018-N-3773-0024 |
|---|---|
| Title | FDA Response re Certain Products Containing Bendamustine |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2018-N-3773 |
| Posted | Feb 20, 2019 |
| Comment period opens | Feb 20, 2019 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: